A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer
Parashar, D.; He, W.; Mon, P.; Plummer, M.; McCoy, M.; Yeang, C.-H.; Beckman, R.
Show abstract
Current Precision Medicine (CPM) matches cancer therapies to consensus molecular characteristics at one or more timepoints. However, cancers contain extensive subclonal heterogeneity leading to dynamic evolution in response to therapy. Mathematical modeling has the potential to optimize timing and sequencing of therapies in a more effective and personalized manner than CPM. Clinical trial designs testing Evolutionary Guided Precision Medicine (EGPM) strategies for preventing or delaying relapse to improve outcomes, are needed. In a simulation, we evaluated Dynamic Precision Medicine (DPM), an EGPM, in a stratified randomized design based on whether the patient was predicted to benefit from DPM, using an evolutionary classifier. We present this new proof-of-concept clinical trial design and perform simulations which show high power, control of false positive rates, and robust performance in the face of anticipated challenges to clinical translation. The design is distinct from common biomarker-driven designs and can provide a robust evaluation of EGPM.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combination Treatment Optimization Using aPan-Cancer Pathway Model 95%
- Chemotherapy-Induced Cachexia and Model-Informed Dosing to Preserve Lean Mass in Cancer Treatment 95%
- A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response 95%
Similar papers in this journal
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 94%
- Targeting Oncogenic Mutations in Colorectal Cancer using Cryptotanshinone 93%
- Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.